TS Tumor Panel (15 Genes) Overview

Slides:



Advertisements
Similar presentations
Combining semiconductor-based sequencing with amplicon-based cancer gene panels: A rapid next-gen approach to clinical cancer genotyping. Christopher L.
Advertisements

Next–generation DNA sequencing technologies – theory & practice
The Challenges Of Sequencing FFPE DNA Using NGS
Molecular Testing of lung cancer in routine practice
High Throughput Sequencing
11 © 2009 PerkinElmer © 2010 PerkinElmer November 20, 2012 DNA Services Overview.
Tag-It TM Mutation Detection Kit for CFTR 70+6 Lorraine Fernandez August 6, 2008.
HaloPlexHS Get to Know Your DNA. Every Single Fragment.
Start slide microRNA ISH in FFPE tissue protocol optimization and diagnostic use Seminar by Charlotte B. Ahler, Senior Scientist.
MOLECULAR DIAGNOSTICS IN ONCOLOGY Dr. Sergey Kovalenko.
HRM Assay and Optimization 1. DNA Quality 2. Amplicon LengthAmplicon  lengths of 100–300 bp 3. Primer Selection 4. Dye Selection 5. MgCl2 Concentration.
An Overview of Applications for the MiSeq and HiSeq 2500 April 4, 2016 Kevin Shianna, Ph.D. Sequencing Specialist - Illumina, Inc. MGC USERS GROUP.
The world leader in serving science Sanger sequencing using Ion AmpliSeq™ primers and libraries Stephen Jackson, Ph.D. Associate Director, Product Applications.
The world leader in serving science Andy Felton Ph.D. Vice President Marketing & Product Management Clinical Sequencing Division Personalized Medicine.
CtDNA NGS testing identified a high-level MET amplification (copy number of 53.6 in circulation) (Figure 1A). The test was repeated on a second tube of.
Anna Buder Institute of Cancer Research Department of Medicine I Medical University of Vienna Liquid Biopsies Analysis of circulating cell-free tumor-DNA.
Overall (regardless of smoking Hx) Prior or current smoking Hx
The Center for Personalized Diagnostics: Past, Present, and FUTURE
Next Generation Sequencing
Quality Control Metrics for DNA Sequencing
Hereditary Cancer Predisposition: Updates in Genetic Testing
Managing Colon cancer in the era of molecular markers
Validation of HLA Typing by NGS
Ultra-Deep Sequencing of Multiplex-PCR Enriched Hotspot and
Cancer Genomics Core Lab
Implementation Insights
Introduction to GENDX HLA typing products
Delivering a Pharmacogenomics NGS service in 5 working days
A B C D Reference Standard (HD728)
Multiplexed Elimination of Wild-Type DNA and High-Resolution Melting Prior to Targeted Resequencing of Liquid Biopsies I. Ladas, M. Fitarelli-Kiehl, C.
Comparison of Clinical Targeted Next-Generation Sequence Data from Formalin-Fixed and Fresh-Frozen Tissue Specimens  David H. Spencer, Jennifer K. Sehn,
Molecular Diagnostic Profiling of Lung Cancer Specimens with a Semiconductor-Based Massive Parallel Sequencing Approach  Volker Endris, Roland Penzel,
Crystal digital PCR for detection and quantification of circulating EGFR mutations in advanced non-small cell lung cancer Cécile Jovelet Postdocoral fellow.
California Department of Justice – Jan Bashinski DNA Laboratory
DNA Extraction of Lung Cancer Samples for Advanced Diagnostic Testing
Reverse Complement PCR: fast, low cost amplicon based NGS
Teagasc/APC Sequencing Facility
Implementation of Amplicon Parallel Sequencing Leads to Improvement of Diagnosis and Therapy of Lung Cancer Patients  Katharina König, PhD, Martin Peifer,
Content and Labeling of Tests Marketed as Clinical “Whole-Exome Sequencing” Perspectives from a cancer genetics clinician and clinical lab director Allen.
A Targeted High-Throughput Next-Generation Sequencing Panel for Clinical Screening of Mutations, Gene Amplifications, and Fusions in Solid Tumors  Rajyalakshmi.
Assessing Copy Number Alterations in Targeted, Amplicon-Based Next-Generation Sequencing Data  Catherine Grasso, Timothy Butler, Katherine Rhodes, Michael.
Automation of the Precision ID NGS System for routine use
Reliable Next-Generation Sequencing of Formalin-Fixed, Paraffin-Embedded Tissue Using Single Molecule Tags  Astrid Eijkelenboom, Eveline J. Kamping, Annemiek.
A Method to Evaluate the Quality of Clinical Gene-Panel Sequencing Data for Single- Nucleotide Variant Detection  Chung Lee, Joon S. Bae, Gyu H. Ryu, Nayoung.
Rosie Coates-Brown Final year Bioinformatics trainee
Volume 19, Issue 3, Pages (March 2017)
Targeted, High-Depth, Next-Generation Sequencing of Cancer Genes in Formalin- Fixed, Paraffin-Embedded and Fine-Needle Aspiration Tumor Specimens  Andrew.
Performance Characteristics and Validation of Next-Generation Sequencing for Human Leucocyte Antigen Typing  Eric T. Weimer, Maureen Montgomery, Rosanne.
Application of Single-Molecule Amplification and Resequencing Technology for Broad Surveillance of Plasma Mutations in Patients with Advanced Lung Adenocarcinoma 
Application of Single-Molecule Amplification and Resequencing Technology for Broad Surveillance of Plasma Mutations in Patients with Advanced Lung Adenocarcinoma 
Molecular Diagnosis of Autosomal Dominant Polycystic Kidney Disease Using Next- Generation Sequencing  Adrian Y. Tan, Alber Michaeel, Genyan Liu, Olivier.
Study of Preanalytic and Analytic Variables for Clinical Next-Generation Sequencing of Circulating Cell-Free Nucleic Acid  Meenakshi Mehrotra, Rajesh.
黃其晟1 塗昭江1 張景年1 黃清水2 1天主教輔仁大學附設醫院 乳房外科 2國泰綜合醫院 外科部
Clinical Validation and Implementation of a Targeted Next-Generation Sequencing Assay to Detect Somatic Variants in Non-Small Cell Lung, Melanoma, and.
Optimization of Routine Testing for MET Exon 14 Splice Site Mutations in NSCLC Patients  Clotilde Descarpentries, PharmD, Frédéric Leprêtre, PhD, Fabienne.
Catherine E. Cottrell, Hussam Al-Kateb, Andrew J. Bredemeyer, Eric J
Markus Rechsteiner, Adriana von Teichman, Jan H
Validation and Implementation of a Custom Next-Generation Sequencing Clinical Assay for Hematologic Malignancies  Michael J. Kluk, R. Coleman Lindsley,
Study of Preanalytic and Analytic Variables for Clinical Next-Generation Sequencing of Circulating Cell-Free Nucleic Acid  Meenakshi Mehrotra, Rajesh.
Comparison of Next-Generation Sequencing Panels and Platforms for Detection and Verification of Somatic Tumor Variants for Clinical Diagnostics  Maksym.
Figure 1. Plasma next-generation sequencing (NGS) assay workflow, comparison of variant allelic fraction with ... Figure 1. Plasma next-generation sequencing.
Cancer WGS Analytical Pipeline Validation
A Rapid, Sensitive Assay to Detect EGFR Mutation in Small Biopsy Specimens from Lung Cancer  Yasushi Yatabe, Toyoaki Hida, Yoshitsugu Horio, Takayuki.
Mutation Detection of Epidermal Growth Factor Receptor and KRAS Genes Using the Smart Amplification Process Version 2 from Formalin-Fixed, Paraffin-Embedded.
The Right Tool for the Job: Two Platforms for Targeted DNA Sequencing
Features & Benefits GENDX SBT Products
Clinical Validation of a Next-Generation Sequencing Screen for Mutational Hotspots in 46 Cancer-Related Genes  Rajesh R. Singh, Keyur P. Patel, Mark J.
Detection of somatic mutations in plasma allows for non-invasive real time therapy response monitoring of lung cancer patients José Carlos Machado.
Genomic & RNA Profiling Core Facility
Development of a Novel Next-Generation Sequencing Assay for Carrier Screening in Old Order Amish and Mennonite Populations of Pennsylvania  Erin L. Crowgey,
Presentation transcript:

TS Tumor Panel (15 Genes) Overview Technical training TS Tumor Panel (15 Genes) Overview Targets relevant regions in 15 cancer-associated genes Content created by NCCN, ESMO, KOLs, and leading pharma companies Enhanced Sample-to-Data Detailed QC steps and simplified pre-defined variant report Workflow optimized for Oncology customers Low FFPE input (20ng) and quick TAT (~36 hours) Sensitive, High-Confidence Variant Detection Identifies somatic mutations at 5% variant allele frequency with >500x coverage Gastric

TruSight Tumor Panel (15 Genes) Sample-To-Data Workflow Solution Technical training TruSight Tumor Panel (15 Genes) Sample-To-Data Workflow Solution FFPE specimens Sample Library Prep Sequencing Analysis Tissue Guidelines Extraction Methods DNA Quant Guidelines FFPE optimized Low DNA-input Multiplex PCR Library QC Guidelines MiSeq V3 Leading Sequencers Sequencing QC MSR Pre-Defined Report Variant Studio 3rd Party Annotation Text underlined is additional QC/analysis that is included in TST 15. These are things that were not included for previous kits. Extends beyond library preparation to enable a more complete solution For Research Use Only. Not for use in diagnostic procedures.

TruSight Tumor Panel (15 Genes) Sample-To-Data Turn Around Time Technical training TruSight Tumor Panel (15 Genes) Sample-To-Data Turn Around Time DAY 1 DAY 2 DAY 3 LIBRARY PREP 7 hours SEQUENCING 27 hours ANALYSIS 1 hour DNA to Analysis in less than 3 days

TruSight Tumor Panel (15 Genes) Content List Key Benefits Gene content: created with industry guidance (NCCN, CAP), leading KOLs, and pharma Relevance: Selected genes have the most analytic relevance for translational tumor research Focused: Small panel ensures quick and comprehensive sample-to-data turnaround time Gene Associated Cancers Target AKT1 Breast E17K BRAF Melanoma*, Colon* Lung VK600E/K/R/M EGFR Lung* Exon 19, 20, 21(L858R), G719A/X, S7681, T790M, L861Q ERBB2 Breast, Lung A775_G776insYVMA FOXL2 Ovary C134W GNA11 Melanoma Q209L GNAQ KIT Gastric, Melanoma* Exons 8, 9, 10, 11, 13, 14, 17, 18 KRAS Colon*, Gastric, Lung* Codons 12, 13, 59, 61, 117, 146 MET Lung*, Colon, Gastric Focal Amplification NRAS Colon* PDGFRA Gastric, Melanoma Exons 12, 14, 18 PIK3CA Lung, Breast, Prostate Exons 9, 20 RET M918T TP53 Lung, Melanoma, Ovary, Colon Full CDS *Indicates in NCCN guideline for cancer type

TruSight Tumor Panel (15 Genes) Recommended QC Technical training TruSight Tumor Panel (15 Genes) Recommended QC STEP QC Method QC METRIC FFPE Tissue Sectioning of tissue with microtome ≥ 140 mm2 (non-melanoma) ≥ 20% tumor DNA Extraction Input concentration fluorometry ≥ 2 ng/µL Library Prep Final concentration by fluorometry ≥ 20 ng/µL final yield Final fragment size on gel (except NTC) ~350bp Sequencing Review of analysis report >93.5% bases >500X

TS Tumor Panel (15 Genes) Library Prep Technical training TS Tumor Panel (15 Genes) Library Prep Mix A Mix B 5 Steps! Multiplex PCR Index PCR Clean Up Validate Sequence

TS Tumor Panel (15 Genes) Multiplex PCR Chemistry Technical training TS Tumor Panel (15 Genes) Multiplex PCR Chemistry Two libraries per sample: Pool A & Pool B

TruSight Tumor Panel (15 Genes) Analysis and Reporting Technical training TruSight Tumor Panel (15 Genes) Analysis and Reporting Illumina Experiment Manager v1.10 Adds TruSight Tumor Panel (15 Genes) workflow and library prep IEM v1.10 will be released upon TST 15 FCS MiSeq Software v2.6 MSR TruSight Tumor Panel (15 Genes) Workflow Alignment and variant calling for TST 15. Creates pre-defined filtered report for easy data interpretation. MCS/MSR 2.6 will be released upon TST 15 FCS VariantStudio TruSight Tumor 15 customers receive license for VariantStudio Enables customized filtering of variants and reporting if pre-defined report is not sufficient

Technical training TruSight Tumor Panel (15 Genes) Pre-defined report makes variant calling easy Streamlined variant filtering and classification Easy to use automated analysis

TruSight Tumor Panel (15 Genes) Data Specifications Technical training TruSight Tumor Panel (15 Genes) Data Specifications PARAMETER DETAIL DNA input requirements 20 ng Panel size 44 kb Amplicon size ~150–175 bp Throughput 8 Samples per MiSeq v3 run Variant frequency 5% Coverage > 93.5% bases covered at > 500×

TruSight Tumor Panel (15 Genes) FFPE input Technical training TruSight Tumor Panel (15 Genes) FFPE input Library concentration vs. ΔCq. ΔCq is a metric used to assess the quality of FFPE DNA. Higher values reflect poorer quality DNA. A library yield of 20ng/ul is recommended for TruSight Tumor Panel (15 Genes).

TruSight Tumor Panel (15 Genes) TST 15 vs TST 26 variant calling Technical training TruSight Tumor Panel (15 Genes) TST 15 vs TST 26 variant calling Gene Coordinate Variant Protein TST 26 TST 15 Smp1 Rep1 MixA Rep2 MixB PDGFRA 55141055 A>G/G 567P 99.6 99.84 99.82 99.73 99.54 EGFR,EGFR-AS1 55249063 G>A/A 99.64 99.93 99.98 TP53 7578469 C>C/A 154G/V 14.4 18.6 20.33 7579472 G>C/C 72P/R 99.52 99.65 99.76 99.77 99.74 100% of variants detected by TruSight Tumor (26 Genes) were detected by TruSight Tumor (15 Genes) and reported at similar frequencies.

TST (15 Genes) – Kit Configuration Technical training TST (15 Genes) – Kit Configuration Library Prep Kit Content TruSight Tumor Kit (15 Genes) TruSight Tumor Panel (15 Genes) 24 Samples, 48 libraries 3 Boxes Includes Library Prep reagents, 24 index combinations, and purification beads Cat # OP-101-1001 Includes 1 Library Prep AND 3 MiSeq Sequencing Kits Cat# OP-101-1002 1 Library Prep Kit ONLY